相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Progress toward active or passive HIV-1 vaccination
Amelia Escolano et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
The effect of statins on influenza-like illness morbidity and mortality
Paul Brassard et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)
Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir
James L. Riley et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial
Meike H. van der Ree et al.
LANCET (2017)
Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis
K. L. Winthrop et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
AASLD guidelines for treatment of chronic hepatitis B
Norah A. Terrault et al.
HEPATOLOGY (2016)
Subcutaneous tuberculosis formation during FOLFIRI and bevacizumab treatment: a case report
Xiao-wei Zheng et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2016)
Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor for relapsed Hodgkin's lymphoma
Joycelyn J. X. Lee et al.
ACTA ONCOLOGICA (2016)
Sharpening nature's tools for efficient tuberculosis control: A review of the potential role and development of host-directed therapies and strategies for targeted respiratory delivery
Gemma O'Connor et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Approved Antiviral Drugs over the Past 50 Years
Erik De Clercq et al.
CLINICAL MICROBIOLOGY REVIEWS (2016)
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial
Bita Shakoory et al.
CRITICAL CARE MEDICINE (2016)
Combination of Tenofovir Disoproxil Fumarate and Peginterferon alpha-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B
Patrick Marcellin et al.
GASTROENTEROLOGY (2016)
Statin adjunctive therapy shortens the duration of TB treatment in mice
Noton K. Dutta et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Restoration of T cell function in chronic hepatitis B patients upon treatment with interferon based combination therapy
Annikki de Niet et al.
JOURNAL OF HEPATOLOGY (2016)
First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B
Antje Blank et al.
JOURNAL OF HEPATOLOGY (2016)
Aiming for cure in HBV and HDV infection
Joerg Petersen et al.
JOURNAL OF HEPATOLOGY (2016)
Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study
Pavel Bogomolov et al.
JOURNAL OF HEPATOLOGY (2016)
Tuberculosis-advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers
Robert S. Wallis et al.
LANCET INFECTIOUS DISEASES (2016)
Inflammatory signaling in human tuberculosis granulomas is spatially organized
Mohlopheni J. Marakalala et al.
NATURE MEDICINE (2016)
Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation
Peilin Li et al.
NATURE MEDICINE (2016)
The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
Danny N. Khalil et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options
Florian A. Lempp et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Circulating Angiogenic Factors as Biomarkers of Disease Severity and Bacterial Burden in Pulmonary Tuberculosis
Nathella Pavan Kumar et al.
PLOS ONE (2016)
Statin treatment is associated with a decreased risk of active tuberculosis: an analysis of a nationally representative cohort
Chih-Cheng Lai et al.
THORAX (2016)
Antimicrobial Resistance in Mycobacterium tuberculosis: The Odd One Out
Vegard Eldholm et al.
TRENDS IN MICROBIOLOGY (2016)
Which therapeutic strategy will achieve a cure for HIV-1?
Anthony R. Cillo et al.
CURRENT OPINION IN VIROLOGY (2016)
Dengue Virus Nonstructural Protein 1 Induces Vascular Leakage through Macrophage Migration Inhibitory Factor and Autophagy
Hong-Ru Chen et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease
Shunsuke Sakai et al.
PLOS PATHOGENS (2016)
TIM3 Mediates T Cell Exhaustion during Mycobacterium tuberculosis Infection
Pushpa Jayaraman et al.
PLOS PATHOGENS (2016)
Dengue Virus NS1 Disrupts the Endothelial Glycocalyx, Leading to Hyperpermeability
Henry Puerta-Guardo et al.
PLOS PATHOGENS (2016)
Pharmacologic Inhibition of Host Phosphodiesterase-4 Improves Isoniazid-Mediated Clearance of Mycobacterium tuberculosis
Selvakumar Subbian et al.
FRONTIERS IN IMMUNOLOGY (2016)
Phosphodiesterase inhibitors as adjunctive therapies for tuberculosis
Bintou Ahmadou Ahidjo et al.
EBIOMEDICINE (2016)
Adjunctive Phosphodiesterase-4 Inhibitor Therapy Improves Antibiotic Response to Pulmonary Tuberculosis in a Rabbit Model
Selvakumar Subbian et al.
EBIOMEDICINE (2016)
Tuberculosis Therapy Modifies the Cytokine Profile, Maturation State, and Expression of Inhibitory Molecules on Mycobacterium tuberculosis-Specific CD4+ T-Cells
Kapil K. Saharia et al.
PLOS ONE (2016)
Mycobacterium tuberculosis exploits the formation of new blood vessels for its dissemination
Helena Polena et al.
SCIENTIFIC REPORTS (2016)
High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trial
Nestan Tukvadze et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2015)
Preclinical and Clinical Evidence of Mycobacterium tuberculosis Persistence in the Hypoxic Niche of Bone Marrow Mesenchymal Stem Cells after Therapy
Jaishree Garhyan et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
LAG3 Expression in Active Mycobacterium tuberculosis Infections
Bonnie L. Phillips et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
The role of immunophilins in viral infection
Sam Hopkins et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2015)
Presence of multiple lesion types with vastly different microenvironments in C3HeB/FeJ mice following aerosol infection with Mycobacterium tuberculosis
Scott M. Irwin et al.
DISEASE MODELS & MECHANISMS (2015)
Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis
Jean-Philippe Lanoix et al.
DISEASE MODELS & MECHANISMS (2015)
Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses
Anne Lenaerts et al.
IMMUNOLOGICAL REVIEWS (2015)
Nonclinical Models for Antituberculosis Drug Development: A Landscape Analysis
Tawanda Gumbo et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial
Peter Daley et al.
LANCET INFECTIOUS DISEASES (2015)
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
Kai Deng et al.
NATURE (2015)
Guarding the frontiers: the biology of type III interferons
Andreas Wack et al.
NATURE IMMUNOLOGY (2015)
HIV-1 and interferons: who's interfering with whom?
Tomas Doyle et al.
NATURE REVIEWS MICROBIOLOGY (2015)
Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis
Guido V. Bloemberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance
Stefany Moreno-Gamez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery
Meenal Datta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity
Naphak Modhiran et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Tim-3 blocking rescue macrophage and T cell function against Mycobacterium tuberculosis infection in HIV plus patients
Isabel Sada-Ovalle et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2015)
Phenylbutyrate Is Bacteriostatic against Mycobacterium tuberculosis and Regulates the Macrophage Response to Infection, Synergistically with 25-Hydroxy-Vitamin D3
Anna K. Coussens et al.
PLOS PATHOGENS (2015)
Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis
Mamoudou Maiga et al.
EBIOMEDICINE (2015)
Statin Treatment and Mortality: Propensity Score-Matched Analyses of 2007-2008 and 2009-2010 Laboratory-Confirmed Influenza Hospitalizations
Matthew R. Laidler et al.
OPEN FORUM INFECTIOUS DISEASES (2015)
Pulmonary embolism and reactivation of tuberculosis during everolimus therapy in a kidney transplant recipient
Jolanta Barbara Fijałkowska-Morawska et al.
Annals of Transplantation (2015)
Verapamil Increases the Bactericidal Activity of Bedaquiline against Mycobacterium tuberculosis in a Mouse Model
Shashank Gupta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Functional drug screening reveals anticonvulsants as enhancers of mTOR-independent autophagic killing of Mycobacterium tuberculosis through inositol depletion
Mark Schiebler et al.
EMBO MOLECULAR MEDICINE (2015)
Inflammation and tuberculosis: host-directed therapies
A. Zumla et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Mycobacterium tuberculosis dysregulates MMP/TIMP balance to drive rapid cavitation and unrestrained bacterial proliferation
Andre Kuebler et al.
JOURNAL OF PATHOLOGY (2015)
Interception of host angiogenic signalling limits mycobacterial growth
Stefan H. Oehlers et al.
NATURE (2015)
Gender-Dependent Differences in Plasma Matrix Metalloproteinase-8 Elevated in Pulmonary Tuberculosis
Tarangini Sathyamoorthy et al.
PLOS ONE (2015)
PD-1, PD-L1 and PD-L2 Gene Expression on T-Cells and Natural Killer Cells Declines in Conjunction with a Reduction in PD-1 Protein during the Intensive Phase of Tuberculosis Treatment
Syeda S. Hassan et al.
PLOS ONE (2015)
Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial
Akhirunnesa Mily et al.
PLOS ONE (2015)
Advancing host-directed therapy for tuberculosis
Robert S. Wallis et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Bone Marrow Mesenchymal Stem Cells Provide an Antibiotic-Protective Niche for Persistent Viable Mycobacterium tuberculosis that Survive Antibiotic Treatment
Gillian Beamer et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Tuberculosis, Pulmonary Cavitation, and Matrix Metalloproteinases
Catherine W. M. Ong et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Lung-Residing Myeloid-derived Suppressors Display Dual Functionality in Murine Pulmonary Tuberculosis
Julia K. Knaul et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Statins Increase Rifampin Mycobactericidal Effect
Livia Silva Lobato et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients
Meike H. van der Ree et al.
ANTIVIRAL RESEARCH (2014)
Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series
Corine E. Delsing et al.
BMC INFECTIOUS DISEASES (2014)
Interferon Lambda Alleles Predict Innate Antiviral Immune Responses and Hepatitis C Virus Permissiveness
Timothy Sheahan et al.
CELL HOST & MICROBE (2014)
Analysis of Th1, Th17 and regulatory T cells in tuberculosis case contacts
R. E. Garcia Jacobo et al.
CELLULAR IMMUNOLOGY (2014)
The pharmacokinetics of conventional and bioenhanced tablet formulations of danirixin (GSK1325756) following oral administration in healthy, elderly, human volunteers
Bruce E. Miller et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2014)
Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes
Yi Ni et al.
GASTROENTEROLOGY (2014)
Unanticipated Mycobacterium tuberculosis complex culture inhibition by immune modulators, immune suppressants, a growth enhancer, and vitamins A and D: clinical implications
Robert J. Greenstein et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2014)
A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection
Andrew J. Muir et al.
JOURNAL OF HEPATOLOGY (2014)
Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG study
Patrick Miailhes et al.
JOURNAL OF HEPATOLOGY (2014)
All-Trans Retinoic Acid-Triggered Antimicrobial Activity against Mycobacterium tuberculosis Is Dependent on NPC2
Matthew Wheelwright et al.
JOURNAL OF IMMUNOLOGY (2014)
Statin Therapy Reduces the Mycobacterium tuberculosis Burden in Human Macrophages and in Mice by Enhancing Autophagy and Phagosome Maturation
Suraj P. Parihar et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Alteration of serum inflammatory cytokines in active pulmonary tuberculosis following anti-tuberculosis drug therapy
Imran Hussain Chowdhury et al.
MOLECULAR IMMUNOLOGY (2014)
Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
Katrin D. Mayer-Barber et al.
NATURE (2014)
Reprogramming human endothelial cells to haematopoietic cells requires vascular induction
Vladislav M. Sandler et al.
NATURE (2014)
Parallels between Cancer and Infectious Disease
Richard S. Hotchkiss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Metformin as adjunct antituberculosis therapy
Amit Singhal et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Tumor necrosis factor alpha in mycobacterial infection
Anca Dorhoi et al.
SEMINARS IN IMMUNOLOGY (2014)
Perspectives on host adaptation in response to Mycobacterium tuberculosis: Modulation of inflammation
Anca Dorhoi et al.
SEMINARS IN IMMUNOLOGY (2014)
Programmed death-1 receptor suppresses γ-IFN producing NKT cells in human tuberculosis
Amar Singh et al.
TUBERCULOSIS (2014)
Stem-Cell-Based Gene Therapy for HIV Infection
Anjie Zhen et al.
VIRUSES-BASEL (2014)
Manipulation of the Mononuclear Phagocyte System by Mycobacterium tuberculosis
Geanncarlo Lugo-Villarino et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Novel Vaccination Strategies against Tuberculosis
Peter Andersen et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
HIV entry: a game of hide-and-fuse?
Gregory B. Melikyan
CURRENT OPINION IN VIROLOGY (2014)
Identification of Host-Targeted Small Molecules That Restrict Intracellular Mycobacterium tuberculosis Growth
Sarah A. Stanley et al.
PLOS PATHOGENS (2014)
Allele-Specific Induction of IL-1β Expression by C/EBPβ and PU.1 Contributes to Increased Tuberculosis Susceptibility
Guoliang Zhang et al.
PLOS PATHOGENS (2014)
Decreases in Colonic and Systemic Inflammation in Chronic HIV Infection after IL-7 Administration
Irini Sereti et al.
PLOS PATHOGENS (2014)
Treatment of Progressive Multifocal Leukoencephalopathy With Interleukin 7
Karl B. Alstadhaug et al.
JAMA NEUROLOGY (2014)
Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial
Aliaksandr Skrahin et al.
LANCET RESPIRATORY MEDICINE (2014)
Reverse translation in tuberculosis: neutrophils provide clues for understanding development of active disease
Anca Dorhoi et al.
FRONTIERS IN IMMUNOLOGY (2014)
Corticosteroid Effects on Sputum Culture in Pulmonary Tuberculosis: A Meta-Regression Analysis
Robert S. Wallis
OPEN FORUM INFECTIOUS DISEASES (2014)
Dengue pathogenesis: a disease driven by the host response
Byron E.E. Martina
SCIENCE PROGRESS (2014)
Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis
Katherine Chang et al.
CRITICAL CARE (2014)
Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patient
Vegard Eldholm et al.
GENOME BIOLOGY (2014)
Acceleration of Tuberculosis Treatment by Adjunctive Therapy with Verapamil as an Efflux Inhibitor
Shashank Gupta et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis'
Nawal Salahuddin et al.
BMC INFECTIOUS DISEASES (2013)
TNF Dually Mediates Resistance and Susceptibility to Mycobacteria via Mitochondrial Reactive Oxygen Species
Francisco J. Roca et al.
CELL (2013)
Active Tuberculosis During Temsirolimus and Bevacizumab Treatment
Chia-Chi Lin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Ibuprofen Therapy Resulted in Significantly Decreased Tissue Bacillary Loads and Increased Survival in a New Murine Experimental Model of Active Tuberculosis
Cristina Vilaplana et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Adjuvant Host-Directed Therapy with Types 3 and 5 but Not Type 4 Phosphodiesterase Inhibitors Shortens the Duration of Tuberculosis Treatment
Mamoudou Maiga et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Inhibiting the Programmed Death 1 Pathway Rescues Mycobacterium tuberculosis-Specific Interferon γ-Producing T Cells From Apoptosis in Patients With Pulmonary Tuberculosis
Amar Singh et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Corticosteroids for prevention of mortality in people with tuberculosis: a systematic review and meta-analysis
Julia A. Critchley et al.
LANCET INFECTIOUS DISEASES (2013)
Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach
Richard S. Hotchkiss et al.
LANCET INFECTIOUS DISEASES (2013)
The TLR4 antagonist Eritoran protects mice from lethal influenza infection
Kari Ann Shirey et al.
NATURE (2013)
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
Michael J. Fuller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production
Alessandro Michelucci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay
Juan D. Guzman et al.
BMJ OPEN (2013)
Corticosteroids for Dengue - Why Don't They Work?
Thi Hanh Tien Nguyen et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial
Jianfeng Wu et al.
CRITICAL CARE (2013)
25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end
Markus H. Heim
NATURE REVIEWS IMMUNOLOGY (2013)
Doxycycline and HIV Infection Suppress Tuberculosis-induced Matrix Metalloproteinases
Naomi F. Walker et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
ESX-1 dependent impairment of autophagic flux by Mycobacterium tuberculosis in human dendritic cells
Alessandra Romagnoli et al.
AUTOPHAGY (2012)
Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections
David M. Tobin et al.
CELL (2012)
Effects of Short-Course Oral Corticosteroid Therapy in Early Dengue Infection in Vietnamese Patients: A Randomized, Placebo-Controlled Trial
Dong T. H. Tam et al.
CLINICAL INFECTIOUS DISEASES (2012)
Effects of Mycobacterium tuberculosis ESAT-6/CFP-10 Fusion Protein on the Autophagy Function of Mouse Macrophages
Lei Zhang et al.
DNA AND CELL BIOLOGY (2012)
Potential efficacy of imiquimod on immunity-related cytokines in murine skin in vivo and in human Langerhans cells in vitro
Xu Miao et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2012)
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver
Shu-hao Hsu et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis
Wei-Chih Tsai et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infection
Sam Hopkins et al.
JOURNAL OF HEPATOLOGY (2012)
The Tim3-Galectin 9 Pathway Induces Antibacterial Activity in Human Macrophages Infected with Mycobacterium tuberculosis
Isabel Sada-Ovalle et al.
JOURNAL OF IMMUNOLOGY (2012)
Abelson Tyrosine Kinase Controls Phagosomal Acidification Required for Killing of Mycobacterium tuberculosis in Human Macrophages
Heiko Bruns et al.
JOURNAL OF IMMUNOLOGY (2012)
IL-7 Restores Lymphocyte Functions in Septic Patients
Fabienne Venet et al.
JOURNAL OF IMMUNOLOGY (2012)
Association Between Use of Statins and Mortality Among Patients Hospitalized With Laboratory-Confirmed Influenza Virus Infections: A Multistate Study
Meredith L. Vandermeer et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Risk of Tuberculosis Reactivation With Tofacitinib (CP-690550)
Mamoudou Maiga et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Vitamins A & D Inhibit the Growth of Mycobacteria in Radiometric Culture
Robert J. Greenstein et al.
PLOS ONE (2012)
PD-1 Blockage Reverses Immune Dysfunction and Hepatitis B Viral Persistence in a Mouse Animal Model
Horng-Tay Tzeng et al.
PLOS ONE (2012)
A Comprehensive Review of Everolimus Clinical Reports: A New Mammalian Target of Rapamycin Inhibitor
Cheryle Gurk-Turner et al.
TRANSPLANTATION (2012)
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
Huan Yan et al.
ELIFE (2012)
Mycobacterium tuberculosis: success through dormancy
Martin Gengenbacher et al.
FEMS MICROBIOLOGY REVIEWS (2012)
Tuberculosis Screening before Anti-Hepatitis C Virus Therapy in Prisons
Sergio Babudieri et al.
EMERGING INFECTIOUS DISEASES (2012)
The effect of vitamin A and zinc supplementation on treatment outcomes in pulmonary tuberculosis: a randomized controlled trial
Marianne E. Visser et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
Assessment of Serum IL-1, IL-2 and IFN-γ Levels in Untreated Pulmonary Tuberculosis Patients: Role in Pathogenesis
Muralidhar K. Katti
ARCHIVES OF MEDICAL RESEARCH (2011)
Imatinib-Sensitive Tyrosine Kinases Regulate Mycobacterial Pathogenesis and Represent Therapeutic Targets against Tuberculosis
Ruth J. Napier et al.
CELL HOST & MICROBE (2011)
Programmed death ligand 1 is over-expressed by neutrophils in the blood of patients with active tuberculosis
Finlay W. McNab et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome
Mark W. Hall et al.
INTENSIVE CARE MEDICINE (2011)
Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: a systematic review
X. -F. Gao et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2011)
Reactivation of tuberculosis during temsirolimus therapy
Romain Coriat et al.
INVESTIGATIONAL NEW DRUGS (2011)
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
Jonathan S. Boomer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
The Role of Aspirin in Childhood Tuberculous Meningitis
Johan F. Schoeman et al.
JOURNAL OF CHILD NEUROLOGY (2011)
Effect of immunomodulatory therapies in patients with pandemic influenza A (H1N1) 2009 complicated by pneumonia
Diego Viasus et al.
JOURNAL OF INFECTION (2011)
Organelle Membrane Proteomics Reveals Differential Influence of Mycobacterial Lipoglycans on Macrophage Phagosome Maturation and Autophagosome Accumulation
Wenqing Shui et al.
JOURNAL OF PROTEOME RESEARCH (2011)
High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial
Adrian R. Martineau et al.
LANCET (2011)
Autophagy in immunity and inflammation
Beth Levine et al.
NATURE (2011)
Phosphodiesterase 4 Inhibition Reduces Innate Immunity and Improves Isoniazid Clearance of Mycobacterium tuberculosis in the Lungs of Infected Mice
Mi-Sun Koo et al.
PLOS ONE (2011)
Thermostable Hexameric Form of Eis (Rv2416c) Protein of M. tuberculosis Plays an Important Role for Enhanced Intracellular Survival within Macrophages
Arsheed A. Ganaie et al.
PLOS ONE (2011)
Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus
Kevin B. Walsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors
Susanne Pfefferle et al.
PLOS PATHOGENS (2011)
Harnessing the biology of IL-7 for therapeutic application
Crystal L. Mackall et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients
Caroline Guignant et al.
CRITICAL CARE (2011)
Penitentiary or penthouse condo: the tuberculous granuloma from the microbe's point of view
Carleitta Paige et al.
CELLULAR MICROBIOLOGY (2010)
Peroxisome proliferator-activated receptor and AMP-activated protein kinase agonists protect against lethal influenza virus challenge in mice
Carson E. Moseley et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2010)
IL-7 Promotes T Cell Viability, Trafficking, and Functionality and Improves Survival in Sepsis
Jacqueline Unsinger et al.
JOURNAL OF IMMUNOLOGY (2010)
Safety, Tolerability, and Mechanisms of Antiretroviral Activity of Pegylated Interferon Alfa-2a in HIV-1-Monoinfected Participants: A Phase II Clinical Trial
David M. Asmuth et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Role of aspirin in tuberculous meningitis: A randomized open label placebo controlled trial
U. K. Misra et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo
Q. M. Nhu et al.
MUCOSAL IMMUNOLOGY (2010)
Réactivation d’une tuberculose sous bithérapie interféron-pégylé et ribavirine pour une hépatite chronique C
N. Belkahla et al.
REVUE DE MEDECINE INTERNE (2010)
Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection
Robert E. Lanford et al.
SCIENCE (2010)
Randomized controlled trial of zinc and vitamin A as co-adjuvants for the treatment of pulmonary tuberculosis
Lovett Lawson et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2010)
CCR5: From Natural Resistance to a New Anti-HIV Strategy
Lucia Lopalco
VIRUSES-BASEL (2010)
Mycobacterium tuberculosis Eis Regulates Autophagy, Inflammation, and Cell Death through Redox-dependent Signaling
Dong-Min Shin et al.
PLOS PATHOGENS (2010)
Granulocyte-Macrophage Colony-stimulating Factor to Reverse Sepsis-associated Immunosuppression A Double-Blind, Randomized, Placebo-controlled Multicenter Trial
Christian Meisel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Adalimumab Treatment of Life-Threatening Tuberculosis
Robert S. Wallis et al.
CLINICAL INFECTIOUS DISEASES (2009)
Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis
Joel Fleury Djoba Siawaya et al.
CYTOKINE (2009)
The Cyclophilin Inhibitor Debio 025 Combined with PEG IFNα2a Significantly Reduces Viral Load in Treatment-Naive Hepatitis C Patients
Robert Flisiak et al.
HEPATOLOGY (2009)
Successful Antiviral and Antituberculosis Treatment With Pegylated Interferon-alfa and Ribavirin in a Chronic Hepatitis C Patient With Pulmonary Tuberculosis
Ming-Chao Tsai et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2009)
Enhancing SIV-specific immunity in vivo by PD-1 blockade
Vijayakumar Velu et al.
NATURE (2009)
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantaion
Gero Huetter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Immunomodulation with Recombinant Interferon-γ1b in Pulmonary Tuberculosis
Rod Dawson et al.
PLOS ONE (2009)
TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection
Jerry R. Aldridge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Effect of matrix metalloproteinase-9-1562C/T gene polymorphism on manifestations of pulmonary tuberculosis
Seung Heon Lee et al.
TUBERCULOSIS (2009)
Essential Role of Cyclophilin A for Hepatitis C Virus Replication and Virus Production and Possible Link to Polyprotein Cleavage Kinetics
Artur Kaul et al.
PLOS PATHOGENS (2009)
Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury
Yumiko Imai et al.
CELL (2008)
Therapeutic Use of Infliximab in Tuberculosis to Control Severe Paradoxical Reaction of the Brain and Lymph Nodes
Timothy K. Blackmore et al.
CLINICAL INFECTIOUS DISEASES (2008)
Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates
Laura E. Via et al.
INFECTION AND IMMUNITY (2008)
Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis
Javier O. Jurado et al.
JOURNAL OF IMMUNOLOGY (2008)
Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro
Feng Yang et al.
JOURNAL OF VIROLOGY (2008)
Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein
Joerg Petersen et al.
NATURE BIOTECHNOLOGY (2008)
Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus
Bo-Jian Zheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Mycobacterial persistance requires the utilization of host cholesterol
Amit K. Pandey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Small molecule enhancers of rapamycin-induced TOR inhibition promote autophagy, reduce toxicity in Huntington's disease models and enhance killing of mycobacteria by macrophages
R. Andres Floto et al.
AUTOPHAGY (2007)
Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice
Noton Kumar Dutta et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Cutting edge:: Vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin
Philip T. Liu et al.
JOURNAL OF IMMUNOLOGY (2007)
Increased survival after gemfibrozil treatment of severe mouse influenza
Alison Budd et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins
Floyd J. Frost et al.
CHEST (2007)
Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis
Sean T. Byrne et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Critical Role of Methylglyoxal and AGE in Mycobacteria-Induced Macrophage Apoptosis and Activation
Helmy Rachman et al.
PLOS ONE (2006)
Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA
CL Jopling et al.
SCIENCE (2005)
Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients
AJ Rosenbloom et al.
CHEST (2005)
The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor
C Watson et al.
MOLECULAR PHARMACOLOGY (2005)
Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: A phase 2 clinical trial in Uganda
H Mayanja-Kizza et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Adjunctive thalidomide therapy for childhood tuberculous meningitis: Results of a randomized study
JF Schoeman et al.
JOURNAL OF CHILD NEUROLOGY (2004)
Six-month therapy with aerosolized interferon-γ for refractory multidrug-resistant pulmonary tuberculosis
WJ Koh et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2004)
A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis
RS Wallis et al.
AIDS (2004)
Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages
MG Gutierrez et al.
CELL (2004)
Cyclophilin A regulates TCR signal strength in CD4+ T cells via a proline-directed conformational switch in Itk
J Colgan et al.
IMMUNITY (2004)
Adjuvant interferon gamma in patients with drug-resistant pulmonary tuberculosis:: a pilot study -: art. no. 44
R Suárez-Méndez et al.
BMC INFECTIOUS DISEASES (2004)
Vascular endothelial growth factor levels in active pulmonary tuberculosis
F Alatas et al.
CHEST (2004)
Mycobacterium tuberculosis growth at the cavity surface:: a microenvironment with failed immunity
G Kaplan et al.
INFECTION AND IMMUNITY (2003)
Medical progress: The pathophysiology and treatment of sepsis.
RS Hotchkiss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes
K Watashi et al.
HEPATOLOGY (2003)
The role of prostaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis
JM Moreno et al.
IMMUNOLOGY (2002)
Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells
D Braaten et al.
EMBO JOURNAL (2001)
Pentoxifylline treatment of mice with chronic pulmonary tuberculosis accelerates the development of destructive pathology
J Turner et al.
IMMUNOLOGY (2001)
Increased serum level of vascular endothelial growth factor in pulmonary tuberculosis
W Matsuyama et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Therapeutic effect of anti-macrophage inflammatory protein 2 antibody on influenza virus-induced pneumonia in mice
S Sakai et al.
JOURNAL OF VIROLOGY (2000)
分享论文
